How much is Bluejay Therapeutics worth in 2026?

Bluejay Therapeutics has a current valuation of $820.0M based on their Merger/Acquisition round and secondary market data.

How much funding has Bluejay Therapeutics raised?

Bluejay Therapeutics has raised $243.0M in total funding across 1 funding rounds.

Bluejay Therapeutics

Drug DiscoveryWebsite

Bluejay Therapeutics valuation and funding history | Last updated: December 6, 2025 | 1 funding rounds

Current Valuation

$820.0M

As of December 6, 2025

Total Funding Raised

$243.0M

Across 1 round

Last Round

Merger/Acquisition

$820.0M

Last Funding

Dec 2025

Funding date

Capital Efficiency

3.37x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 9, 2024	Later Stage VC (Series C)	$182.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Bluejay Therapeutics is currently valued at $820.0M as of December 6, 2025. The company has raised a total of $243.0M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 3.37x, Bluejay Therapeutics has achieved a valuation that is 3.37 times the total capital raised.

Track Bluejay Therapeutics Valuation Updates

Get notified when Bluejay Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Bluejay Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Bluejay Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Bluejay Therapeutics Worth in 2026?

Bluejay Therapeutics is a leading private company in the Drug Discovery sector. Track Bluejay Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Bluejay Therapeutics Valuation is Determined

Private company valuations like Bluejay Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.